ReviewCancer immunology, immunotherapy : CII2009
TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors.
Cristina Maccalli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it